KNSA Kiniksa Pharmaceuticals Interna
$76.27▼ -0.27%
Healthcare
Other
After hours
$76.27▲ +0.00%
Sep 11, 7:30 PM ET
Volume 358.0K
Avg Volume (10D) 501.1K
Key Metrics & Fundamentals
Market Cap
$5.95B
P/E Ratio
77.0
Div Yield
–%
52W Range
35.20 - 82.94
% vs 50 MA
4.38%
% vs 200 MA
42.32%
RSI-14
48.5
MACD Histogram
-0.8400
Beta (1Y vs SPY)
0.23
Free Cash Flow
$46.53M
Gross Rev
$243.60M
Gross Profit
$131.96M
EBITDA
$27.67M
COGS
$111.64M
Operating Exp
$104.77M
Operating Income
$27.19M
EBIT
$27.19M
Pretax Income
$31.15M
Net Income
$25.43M
EPS (Diluted)
0.30
Price & Volume History
Loading chart…
Recent News
Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat
Investor's Business Daily · Sep 10, 2026 4:35 PM
Kiniksa Pharmaceuticals to Present at Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire · Sep 4, 2026 8:01 PM
TGTX Stock Outperforms 95% of Stocks. Here's Why.
Investor's Business Daily · Aug 24, 2026 4:56 PM
Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan
Investor's Business Daily · Aug 21, 2026 8:11 PM
Three Biotech Stocks Stick Out With Their Stellar Charts
Investor's Business Daily · Aug 21, 2026 4:09 PM
Kiniksa Highlights ARCALYST Growth as KPL-387 Advances Into Phase 3
MarketBeat · Aug 15, 2026 1:01 AM
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
GlobeNewswire · Aug 7, 2026 8:01 PM
KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook
Zacks · Aug 3, 2026 2:00 PM
MDGL Stock Down Despite Q2 Beat, MASH Drug Drives Top-Line Y/Y Growth
Zacks · Jul 31, 2026 3:34 PM
Earnings Estimates Rising for Kiniksa Pharmaceuticals International, plc (KNSA): Will It Gain?
Zacks · Jul 30, 2026 4:20 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See KNSA's money flow as a full page
Social Sentiment
No Reddit posts found for KNSA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.